⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for sham

Every month we try and update this database with for sham cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic LeukemiaNCT02336282
Acute Lymphobla...
transcranial Di...
Sham
Cognitive Asses...
Brain Games Sti...
18 Years - St. Jude Children's Research Hospital
Remote Ischemic Preconditioning in Head and Neck Cancer Reconstruction - A Randomized Controlled TrialNCT02548377
Head and Neck N...
Remote ischemic...
Sham
18 Years - Aarhus University Hospital Skejby
Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLCNCT03553485
Lung Cancer, No...
Transcutaneous ...
Sham
Radiotherapy
18 Years - Vrije Universiteit Brussel
Laser Treatment of Genito-urinary Syndrome in WomenNCT03238053
Laser-Induced S...
Breast Cancer
Endometrial Can...
Menopause
Vaginal Atrophy
Bladder, Overac...
Vaginal laser t...
sham
laser system
- Herning Hospital
A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)NCT05850520
Macular Edema S...
Aflibercept, VE...
Aflibercept, VE...
Sham
Fluorescein
18 Years - Bayer
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)NCT00943072
Macular Edema S...
VEGF Trap-Eye 2...
Sham
18 Years - Regeneron Pharmaceuticals
ExAblate (MRgFUS) Treatment of Metastatic Bone Tumors for the Palliation of PainNCT00656305
Bone Metastases
Multiple Myelom...
ExAblate MRfFUS
Sham
18 Years - 100 YearsInSightec
Effects of VNS on RT-induced Inflammation and Prognosis of Patients With NSCLCNCT03553485
Lung Cancer, No...
Transcutaneous ...
Sham
Radiotherapy
18 Years - Vrije Universiteit Brussel
Treatment Of Radiation Retinopathy TrialNCT00811200
Uveal Melanoma
ranibizumab
triamcinolone a...
sham
18 Years - Leiden University Medical Center
ESP Block for Laparoscopic Nephrectomy SurgeriesNCT04085237
Kidney Cancer
Post-surgical P...
Ropivacaine inj...
Sham
18 Years - McMaster University
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO)NCT00943072
Macular Edema S...
VEGF Trap-Eye 2...
Sham
18 Years - Regeneron Pharmaceuticals
A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)NCT05850520
Macular Edema S...
Aflibercept, VE...
Aflibercept, VE...
Sham
Fluorescein
18 Years - Bayer
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: